
Site burden is now measured through satisfaction surveys, in-the-moment check-ins, and adoption patterns, but each method catches a different moment, and the gaps between them decide whether teams can act before burden becomes risk.
TFS International has signed a new three-year partnership agreement with OmniComm Systems, Inc. in which TFS will use OmniComm’s TrialMaster EDC technology to develop clinical studies in multiple TFS research sites around the world. Clinical trial managment along with new medicines being brought to the market are a few of the benefits to this collaboration.
Read the full release






